Targeting MCL-1/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid LeukemiaKevin Lin, Kris C. Wood, Peter Winter et al.|Scientific Reports|2016Cited by 178
Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary ConvergenceKatherine R. Singleton, Kris C. Wood, Haley E. Manchester et al.|Cell Reports|2017Cited by 109
A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor EvolutionGrace R. Anderson, Kris C. Wood, Peter Winter et al.|Cell Reports|2017Cited by 86
<i>PIK3CA</i> mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translationGrace R. Anderson, Kris C. Wood, Suzanne E. Wardell et al.|Science Translational Medicine|2016Cited by 58
Melanoma Therapeutic Strategies That Select Against Resistance by Exploiting MYC-Driven Evolutionary ConvergenceKatherine R. Singleton, Kris C. Wood, Lorin Crawford et al.|SSRN Electronic Journal|2018Cited by 6